Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4151574 | 1.00 | CA4 (0.42) | CA4LTA4HTSHRLMNATDP1 | |
| SCHEMBL22129143 | 0.79 | LTA4H (0.43) | CA4LTA4HTSHRLMNATDP1 | |
| SCHEMBL27016003 | 0.76 | CA4 (0.44) | CA4LTA4HTSHRLMNATDP1 | |
| SCHEMBL4155588 | 0.75 | LTA4H (0.39) | CA4LTA4HTSHRLMNATDP1 | |
| SCHEMBL22485139 | 0.75 | LTA4H (0.39) | CA4LTA4HTSHRLMNATDP1 | |
| SCHEMBL6193818 | 0.75 | LTA4H (0.39) | CA4LTA4HTSHRTDP1L3MBTL1 | |
| SCHEMBL16760862 | 0.75 | CA4 (0.42) | CA4LTA4HTSHRLMNAL3MBTL1 | |
| SCHEMBL21428538 | 0.75 | CA4 (0.37) | CA4LTA4HTSHRLMNAL3MBTL1 | |
| SCHEMBL9945371 | 0.75 | LTA4H (0.38) | CA4LTA4HTSHRLMNAL3MBTL1 | |
| SCHEMBL9944297 | 0.75 | MAPK1 (0.38) | CA4LTA4HTSHRLMNATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140200134-A1 | Anthranilamide Compounds and their use as Pesticides | BASF SE (DE) | 2014-07-17 | — | — | US | disclosed |
| US-8772290-B2 | Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same | Oscotech Inc. (KR) | 2014-07-08 | — | — | US | disclosed |
| US-20140171316-A1 | ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | BASF SE (DE) | 2014-06-19 | — | — | US | disclosed |
| US-8722678-B2 | Fungicidal oximes and hydrazones | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-05-13 | — | — | US | disclosed |
| US-20130030002-A1 | FUNGICIDAL OXIMES AND HYDRAZONES | E I DUPONT DE NEMOURS AND COMPANY (US) | 2013-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140200134-A1 | Anthranilamide Compounds and their use as Pesticides | ANTXR2, NQO2, AAAS | CA4 298/4885LTA4H 1075/4885TSHR 3329/4885 |
| US-20130030002-A1 | FUNGICIDAL OXIMES AND HYDRAZONES | NOX1, QSOX1, XDH | CA4 699/4885LTA4H 1057/4885TSHR 4101/4885 |
| US-20140171316-A1 | ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | ANTXR2, NQO2, AAAS | CA4 298/4885LTA4H 1075/4885TSHR 3329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.